Advanced search
Publication Cover
Biomarkers Volume 22, 2017 - Issue 3-4
Submit an article Journal homepage
137
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Biomarker response and therapy prediction in renal denervation therapy – the role of MR-proadrenomedullin in a multicenter approach

Johannes Tobias NeumannDepartment of General and Interventional Cardiology, Hamburg University Heart Center, Hamburg, Germany; Correspondence[email protected]
,
Marius SchwergDepartment of Cardiology and Division of Emergency Medicine, Campus Virchow Klinikum and Campus Charité Mitte, Charité Universitätsmedizin Berlin, Germany;
,
Oliver DörrDepartment of Internal Medicine I, Cardiology/Angiology, Giessen University, Giessen, Germany;
,
Kai MortensenDepartment of Medical Clinic II, Cardiology, University of Lübeck, Lübeck, Germany
,
Klaas FranzenDepartment of Medical Clinic II, Cardiology, University of Lübeck, Lübeck, Germany
,
Tanja ZellerDepartment of General and Interventional Cardiology, Hamburg University Heart Center, Hamburg, Germany;
,
Francisco OjedaDepartment of General and Interventional Cardiology, Hamburg University Heart Center, Hamburg, Germany;
,
Stefan BlankenbergDepartment of General and Interventional Cardiology, Hamburg University Heart Center, Hamburg, Germany;
,
Christian HammDepartment of Internal Medicine I, Cardiology/Angiology, Giessen University, Giessen, Germany;
,
Holger NefDepartment of Internal Medicine I, Cardiology/Angiology, Giessen University, Giessen, Germany;
,
Verena StanglDepartment of Cardiology and Division of Emergency Medicine, Campus Virchow Klinikum and Campus Charité Mitte, Charité Universitätsmedizin Berlin, Germany;
,
Martin MöckelDepartment of Cardiology and Division of Emergency Medicine, Campus Virchow Klinikum and Campus Charité Mitte, Charité Universitätsmedizin Berlin, Germany;
&
Karsten SydowDepartment of General and Interventional Cardiology, Hamburg University Heart Center, Hamburg, Germany;
show all
Pages 225-231 | Received 15 Oct 2015, Accepted 12 Mar 2016, Published online: 06 May 2016

References

  • Bhatt DL, Kandzari DE, O'neill WW, et al. (2014). A controlled trial of renal denervation for resistant hypertension. N Engl J Med 370:1393–401.
  • Bohm M, Mahfoud F. (2014). SYMPLICITY HTN-3 trial: what is it and what does it mean? Eur Heart J 35:1697–8.
  • Charles CJ, Jardine DL, Nicholls MG, Richards AM. (2005). Adrenomedullin increases cardiac sympathetic nerve activity in normal conscious sheep. J Endocrinol 187:275–81.
  • Christ-Crain M, Morgenthaler NG, Struck J, et al. (2005). Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study. Critical Care 9:R816–24.
  • Dorr O, Liebetrau C, Mollmann H, et al. (2014). Soluble fms-like tyrosine kinase-1 and endothelial adhesion molecules (intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1) as predictive markers for blood pressure reduction after renal sympathetic denervation. Hypertension 63:984–90.
  • Esler MD, Krum H, Schlaich M, et al. (2012). Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the symplicity HTN-2 randomized, controlled trial. Circulation 126:2976–82.
  • Funke-Kaiser A, Havulinna AS, Zeller T, et al. (2014). Predictive value of midregional pro-adrenomedullin compared to natriuretic peptides for incident cardiovascular disease and heart failure in the population-based FINRISK 1997 cohort. Ann Med 46:155–62.
  • Ishimitsu T, Nishikimi T, Saito Y, et al. (1994). Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest 94:2158–61.
  • Kearney PM, Whelton M, Reynolds K, et al. (2005). Global burden of hypertension: analysis of worldwide data. Lancet 365:217–23.
  • Khan SQ, O'brien RJ, Struck J, et al. (2007). Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study. J Am Coll Cardiol 49:1525–32.
  • Kitamura K, Kangawa K, Eto T. (2002). Adrenomedullin and PAMP: discovery, structures, and cardiovascular functions. Microsc Res Technique 57:3–13.
  • Kitamura K, Kangawa K, Kawamoto M, et al. (1993). Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192:553–60.
  • Kohno M, Hanehira T, Kano H, et al. (1996). Plasma adrenomedullin concentrations in essential hypertension. Hypertension 27:102–7.
  • Krum H, Schlaich M, Whitbourn R, et al. (2009). Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373:1275–81.
  • Mahfoud F, Luscher TF, Andersson B, et al.; European Society Of Cardiology (2013a). Expert consensus document from the European Society of Cardiology on catheter-based renal denervation. Eur Heart J 34:2149–57.
  • Mahfoud F, Ukena C, Schmieder RE, et al. (2013b). Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension. Circulation 128:132–40.
  • Maisel A, Mueller C, Nowak R, et al. (2010). Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol 55:2062–76.
  • Masson S, Latini R, Carbonieri E, et al. (2010). The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trial. Eur J Heart Fail 12:338–47.
  • McMurray JJ, Adamopoulos S, Anker SD, et al.; ESC Committee for Practice Guidelines. (2012). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33:1787–847.
  • Morgenthaler NG, Struck J, Alonso C, Bergmann A. (2005). Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. Clin Chem 51:1823–9.
  • Neumann JT, Tzikas S, Funke-Kaiser A, et al. (2013). Association of MR-proadrenomedullin with cardiovascular risk factors and subclinical cardiovascular disease. Atherosclerosis 228:451–9.
  • von Haehling S, Filippatos GS, Papassotiriou J, et al. (2010). Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure. Eur J Heart Fail 12:484–91.
  • Zuern CS, Eick C, Rizas KD, et al. (2013). Impaired cardiac baroreflex sensitivity predicts response to renal sympathetic denervation in patients with resistant hypertension. J Am Coll Cardiol 62:2124–30.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.